1. Introduction
===============

Essential oils possess a wide spectrum of pharmacological activities, e.g. anti-inflammatory, hyperemic, spasmolytic, expectorant, diuretic, choleretic, carminative or antiseptic effects \[[@B1-pharmaceuticals-01-00001]\]. For this reason, essential oils became officinal drugs in many countries ([Table 1](#pharmaceuticals-01-00001-t001){ref-type="table"}), which is documented in their respective pharmacopoeias \[[@B2-pharmaceuticals-01-00001]\].

However, essential oils are not free of side effects and skin, respiratory- and gastrointestinal tract irritations, allergic reactions, phototoxicity, abortive as well as mutagenic and carcinogenic properties may be caused \[[@B1-pharmaceuticals-01-00001]\]. Even cases of poisoning of children by volatile oils, such as eucalyptus, sassafras, turpentine, wintergreen, chenopodium and citronella oil had occurred \[[@B3-pharmaceuticals-01-00001]\]. Moreover, care has to be taken with essential oils or preparations containing menthol **1** or camphor **2**.

In infants both compounds may cause respiratory depression or even death (Kratschmer Reflex), when given directly into the nose or close to the nose onto skin \[[@B4-pharmaceuticals-01-00001]\]. Adverse effects similar to the 'Kratschmer Reflex' may occur also with other compounds from essential oils and can not be predicted from animal experiments.

The use of essential oils for healing purposes is recommended especially in the treatment of catarrhal diseases. Their administration to children presupposes the selection of safe oils and the determination of appropriate doses to avoid side effects. Among officinal essential oils only a few oils come into question. [Table 2](#pharmaceuticals-01-00001-t002){ref-type="table"} shows their appropriate doses that are calculated from adult doses and respect body weight, size and surface area of children \[[@B5-pharmaceuticals-01-00001]\].
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###### 

Officinal Essential Oils Listed in Various Pharmacopoeias.

                             Country                                                 Austria   Europe   France   Germany   Italy   Japan   Switzerland   United Kingdom   USA
  -------------------------- ------------------------------------------------------- --------- -------- -------- --------- ------- ------- ------------- ---------------- -----
  **Anise (Staranise)**      Pimpinella anisum L.; Illicium verum Hook                         X        X        X         X                             X                
  **Ambrose**                Chenopodium ambrosioides L.                                                                   X                                              
  **Bitter-Orange-Flower**   Citrus aurantium L. subspecies aurantium                          X        X        X                                       X                
  **Camellia**               Camellia japonica L.                                                                                  X                                      
  **Caraway**                Carum carvi L.                                          X                           X                                       X                X
  **Cardamom**               Elettaria cardamomum Maton var. minuscula Burkill                                                                           X                
  **Chamomile**              Matricaria chamomilla L.                                X                           X                                                        
  **Chia**                   Salvia lavandulifolia Vahl (Salvia hispanica)                              X        X                                                        
  **Cinnamon**               Cinnamomum cassia Blume; C. ceylanicum Nees             X                           X                 X       X             X                
  **Citronella**             Cymbopogon winterianus Jovitt                           X                                                     X                              
  **Clove**                  Syzygium aromaticum Merril et L.M. Perry                          X        X        X         X       X                     X                
  **Coriander**              Coriandrum sativum L.                                                                                                       X                
  **Dill**                   Anethum graveolens L.                                                                                 X                     X                
  **Eucalyptus**             Eucalyptus globulus Labillardiere etc.                            X        X        X         X       X                     X                
  **Fennel**                 Foeniculum vulgare Miller var. vulgare                  X                           X                 X       X                              
  **Juniper**                Juniperus communis L.                                   X                                                     X                              
  **Laurel**                 Laurus nobilis L.                                       X                                                                                    
  **Lavender**               Lavandula angustifolia Miller                                     X        X        X                                       X                
  **Lemon**                  Citrus limon (L.) Burman filius                                   X        X        X         X                             X                
  **Mentha**                 Mentha arvensis L. var. piperascens Holmes ex Christy                                                 X                                      
  **Mint dementholized**                                                                       X        X                                  X                              
  **Norway spruce**          Picea abies (L.) Karsten; Abies sibirica Ledebour                          X        X                                                        
  **Nutmeg**                 Myristica fragrans Houttuyn                             X                  X                                  X             X                
  **Orange**                 Citrus sinensis Osbeck                                                     X                  X       X                     X                
  **Peppermint**             Mentha piperita L.                                                X        X        X         X                             X                X
  **Pine needle**            Pinus silvestris L.                                                                 X                                                        
  **Pumilio Pine**           Pinus mugo Turra var. pumilio Zenari                    X                                                     X                              
  **Rose**                   Rosa gallica L. etc.                                                                                                                         X
  **Rosemary**               Rosmarinus officinalis L.                               X                           X                         X                              
  **Sage**                   Salvia officinalis L.                                                               X                         X                              
  **Spearmint**              Mentha spicata L.; Mentha cardiaca Bak.                                    X        X                                       X                
  **Tangerine**              Citrus reticulata Blanco (Citrus nobilis Andreus)                          X                  X                                              
  **Tea tree**               Melaleuca alternifolia Cheel etc.                                                   X                                                        
  **Thyme**                  Thymus vulgaris L.                                                X                 X                                       X                
  **Turpentine rectified**   Pinus palustris Miller; Pinus pinaster Aiton            X                           X                 X       X             X                
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###### 

Essential Oils Used in the Treatment of Catarrhal Diseases of Children.

  Aetherolum                Common oil name                                             Administration   Age of children in years                                      
  ------------------------- ----------------------------------------------------------- ---------------- -------------------------- ----------------- ---------------- ---------------
  **Eucalypti**             Eucalyptus                                                  Inhalation b     1 -- 2 dr                  4 -- 6 dr         4 -- 6 dr        4 -- 6 dr
  **Foeniculi**             Fennel                                                      Oral             \-\-\-\-\-\-\--            \-\-\-\-\-\-\--   0,05 -- 0,2 ml   0,1 -- 0,6 ml
  **Menthae arvensis**      Japanese peppermint                                         Inhalation c     \-\-\-\-\-\-\--            1 -- 3 dr         2 -- 4 dr        3 -- 6 dr
  **Menthae piperitae**     Peppermint                                                  Inhalation c     1 dr                       1 -- 2 dr         2 -- 3 dr        3 -- 4 dr
  **Piceae**                Norway spruce fir, Siberian pine needle                     Inhalation a     2 dr/l                     2 -- 4 dr/l       3 -- 4 dr/l      3 -- 4 dr/l
  **Pini**                  Dwarf or Scots pine needle, Austrian or French turpentine   Inhalation c     1 -- 2 dr                  2 -- 3 dr         3 -- 4 dr/l      3 -- 4 dr/l
  **Terebinthinae rect.**   Rectified turpentine                                        Inhalation a     \-\-\-\-\-\-\--            \-\-\-\-\-\-\--   3 -- 4 dr/l      3 -- 4 dr/l

Notes: a) Inhalation with hot water, b) pure oil is given on a pillow, c) a) or b). Abbreviations used: dr = drops

Most essential oils consist of many, in part over 100 individual compounds, which are responsible as individuals or in their natural composition for beneficial and adverse effects of the respective entire oil. In this paper some effort was done to select safe compounds from essential oils with simultaneously antimicrobial activity against children pathogens and to compare the selected compounds with medicinal antibiotics used for the therapy of children diseases.

Information about treatment of children infections with pure, individual compounds from essential oils is not much available from literature. A very early report described the rectal administration of eugenol **3**, the main constituent of clove oil (*Syzygium aromaticum*), in the trheatment of systemic infections of several children. Eugenol decreased body temperature and reduced fever, however, this was not sufficient to prevent death among all treated patients \[[@B6-pharmaceuticals-01-00001]\].

Further, oral, topical and inhalative administration of camphor **2**, the main constituent of rosemary oil (*Rosmarinum officinale*), is recommended in supportive therapy of respiratory tract infection \[[@B7-pharmaceuticals-01-00001]\].

Because of the limited availability of pharmacological data obtained with living organisms, another selection strategy was necessary as a substitute in the selection of promising antimicrobials. In pharmacology the so-called 'Therapeutic-Index' (TI) is a measure for the effectiveness of pharmacological active drugs \[[@B8-pharmaceuticals-01-00001]\]. It is deduced from laboratory test results and the animal toxicity of compounds, respectively. The use of the TIs presupposes a collection of microbiological inhibitory and toxicological data. Such a collection is already available as a computer database \[[@B9-pharmaceuticals-01-00001]\], which was used for calculating TIs for children pathogenic microorganisms. The so-selected compounds were controlled for side effects as they are documented in materials safety data sheets (MSDS) or in 'Toxicology Reports' \[[@B10-pharmaceuticals-01-00001]\]. The effectiveness on the basis of TI-calculations of the selected compounds was then compared to antibiotics used in the therapy of children infections \[[@B11-pharmaceuticals-01-00001],[@B16-pharmaceuticals-01-00001]\].

2. Material and Methods
=======================

The volume of the database used for the data analysis exceeds 153.000 data records \[[@B9-pharmaceuticals-01-00001]\]. It contains information about 6800 compounds and over 2500 species of bacteria, fungi and yeast, which is scheduled from almost 3000 microbiology and over 4500 toxicology references ([Figure 1](#pharmaceuticals-01-00001-f001){ref-type="fig"}).

![Example of one data record of the antimicrobial database.](pharmaceuticals-01-00001-g001){#pharmaceuticals-01-00001-f001}

Among constituents of higher plants, terpenoids (20.000 data records) and aliphatic compounds (16.000 data records) are the largest groups in the database. The antibiotics database comprises 84.000 data records, of which 53.000 data records relate to officinal drugs being available in Japan, Europe and USA.

The calculation of 'Therapeutic Indices' (TI) is done usually by combining ED~50~ and LD~50~: the effective dose 50 (ED~50~) is the amount causing 50% of a desired effect, and the lethal dose 50 (LD~50~) is the amount causing 50% death of test animals \[[@B8-pharmaceuticals-01-00001]\].

TI calculation used for pharmaceutical products and substances: ![](pharmaceuticals-01-00001-i003.jpg).

In the case of antimicrobials the concentration preventing microbial growth (minimal inhibitory concentration, MIC in ppm) is of interest and was used instead of ED~50~.

Among toxicity data towards animals different types exist depending on the route of administration. Comprehensive toxicological data material exists following oral administration. In the case of skin affections the dermal toxicity of a compound is of interest. Therefore, oral 'Therapeutic Indices' (oral TI) and dermal 'Therapeutic Indices' (dermal TI) are given both.

TI calculation used for antimicrobials:

The 1530 compounds presented in the database are characterized by their oral toxicity and 523 compounds by their dermal toxicity. Defined inhibitory concentrations (MIC) are necessary to calculate 'Therapeutic Indices' (TIs). About 40.000 data records of the entire database yield MIC-data of compounds from higher plants. The number of TIs calculated from combined antimicrobial and toxicological data exceeds 30.000 without antibiotics.

Typical children's diseases, infection sites and causative microorganisms were compiled together ([Table 3](#pharmaceuticals-01-00001-t003){ref-type="table"}) from the 'Merck Manual of Diagnosis and Therapy' \[[@B11-pharmaceuticals-01-00001]\].
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###### 

Diseases caused by Important Children's Pathogens.

  Causative Microorganism                                                                 Children disease                           Localization
  --------------------------------------------------------------------------------------- ------------------------------------------ --------------------------------
  **Streptococcus pneumoniae**                                                            Pneumonia                                  Respiratory tract
                                                                                          Meningitis                                 Nasopharynx
                                                                                          Rhinitis, Sinusitis                        Nose, nasal cavity
                                                                                          Otitis media                               Ear
                                                                                          Conjunctivitis, Orbital cellulitis         Eye
                                                                                          Bacteremia, Sepsis                         Bloodstream
  **Staphylococcus aureus**                                                               Rhinitis, Sinusitis                        Nose, nasal cavity
                                                                                          Conjunctivitis, Orbital cellulitis         Eye
                                                                                          Infectious gastroenteritis                 Gastrointestinal tract
                                                                                          Sepsis                                     Bloodstream
                                                                                          Impetigo, Staphylococcal skin infections   Skin
                                                                                          Staphylococcal scalded skin syndrome       Skin
  **Escherichia coli**                                                                    Pneumonia                                  Respiratory tract
                                                                                          Meningitis                                 Nasopharynx
                                                                                          Urinary tract infections                   Urinary tract
                                                                                          Infectious gastroenteritis                 Gastrointestinal tract
  **Salmonella spec.**                                                                    Bacteremia, Sepsis                         Bloodstream
                                                                                          Infectious gastroenteritis                 Gastrointestinal tract
  **Mycobacterium tuberculosis, M. bovis, M. africanum**                                  Pulmonary tuberculosis Lymphadenopathy     Respiratory tract Lymph nodes
  **Microsporum audouinii, M. canis, M. gypseum, Trichophyton tonsurans, T. violaceum**   Tinea capitis                              Skin, hair
  **Candida albicans**                                                                    Pneumonia                                  Bloodstream, respiratory tract
                                                                                          Nappy (diaper) rush                        Skin
                                                                                          Oral candidiasis                           Mouth
  **Bordetella pertussis**                                                                Pertussis                                  Respiratory tract
  **Haemophilus influenzae**                                                              Epiglottis                                 Respiratory tract
  **Clostridium tetani**                                                                  Tetanus                                    Skin, wounds

The most hazardous infectious for children - according to the statistics of the World Health Organization dating from the year 2001 \[[@B12-pharmaceuticals-01-00001]\] - are shown in [Table 4](#pharmaceuticals-01-00001-t004){ref-type="table"}. Among children's diseases caused by bacteria in particular respiratory infections followed by diarrhea, pertussis, syphilis, meningitis and tetanus are most frequent causes of death.
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###### 

WHO Statistic on Causes of Death among Children in the Year 2001.

  ----------------------------- ---------------------------------------------- -------- --------- ----------------------------------------------- ----------------------------- ------- -------- --------
                                No. cases of death in age group 0 -- 4 years                      No. cases of death in age group 5 -- 14 years                                                  
                                Male                                           Female   Both                                                                                    Male    Female   Both
  Lower respiratory infect.     1070739                                        963096   2033836                                                   Measles                       86435   87434    173868
  Diarrhoeal diseases           685979                                         667149   1353128                                                   Other infectious diseases     62495   53268    115763
  Malaria                       454970                                         502027   956997                                                    Lower respiratory infect.     57849   43601    101450
  Other infectious diseases     308522                                         310123   618645                                                    Diarrhoeal diseases           54967   39016    93983
  Measles                       276372                                         277156   553527                                                    Malaria                       54388   29391    83779
  HIV/AIDS                      178049                                         174069   352118                                                    Tuberculosis                  17257   17584    34842
  Pertussis                     142430                                         142111   284541                                                    HIV/AIDS                      15102   13904    29006
  Tetanus                       100657                                         100784   201441                                                    Tetanus                       12840   12746    25587
  Syphilis                      78084                                          64292    142376                                                    Meningitis                    12623   10605    23229
  Meningitis                    42999                                          36473    79471                                                     Trypanosomiasis               6183    11125    17309
  Tuberculosis                  27979                                          21351    49330                                                     Leishmaniasis                 7135    9663     16797
  Upper respiratory infect.     16179                                          18672    34851                                                     Dengue                        1904    1171     3075
  Dengue                        2730                                           6393     9123                                                      Hepatitis B                   1180    1500     2680
  Leishmaniasis                 4833                                           4040     8872                                                      Upper respiratory infect.     1087    835      1922
  Japanese encephalitis         2133                                           4490     6623                                                      Trichuriasis                  878     907      1785
  Diphtheria                    2470                                           1976     4446                                                      Ascariasis                    869     739      1608
  Trypanosomiasis               2237                                           1245     3482                                                      Japanese encephalitis         1130    357      1487
  Hepatitis B                   1668                                           1782     3450                                                      Hepatitis C                   563     736      1299
  Otitis media                  1420                                           997      2417                                                      Otitis media                  622     222      843
  Ascariasis                    1059                                           1094     2153                                                      Schistosomiasis               159     659      818
  Hepatitis C                   646                                            831      1476                                                      Diphtheria                    518     212      730
  Other intestinal infections   517                                            540      1057                                                      Pertussis                     254     252      506
  Leprosy                       206                                            169      375                                                       Other intestinal infections   111     115      226
  Other STDs                    184                                            140      324                                                       Leprosy                       68      52       120
  Trichuriasis                  227                                            95       323                                                       Poliomyelitis                 45      52       97
  Schistosomiasis               110                                            21       131                                                       Chlamydia                     74      0        74
  Poliomyelitis                 46                                             34       80                                                        Syphilis                      10      15       25
  Gonorrhoea                    0                                              33       33                                                        Other STDs                    3       6        9
  Trachoma                      31                                             0        31                                                        Hookworm disease              9       0        9
  Lymphatic filariasis          31                                             0        31                                                        Chagas disease                4       1        5
  Hookworm disease              5                                              3        7                                                         Gonorrhoea                    0       1        1
  Onchocerciasis                6                                              0        6                                                         Trachoma                      0       1        1
  Chagas disease                4                                              1        5                                                         Lymphatic filariasis          0       0        0
  Chlamydia                     0                                              0        0                                                         Onchocerciasis                0       0        0
  ----------------------------- ---------------------------------------------- -------- --------- ----------------------------------------------- ----------------------------- ------- -------- --------

[Table 5](#pharmaceuticals-01-00001-t005){ref-type="table"}, [Table 6](#pharmaceuticals-01-00001-t006){ref-type="table"}, [Table 7](#pharmaceuticals-01-00001-t007){ref-type="table"}, [Table 8](#pharmaceuticals-01-00001-t008){ref-type="table"}, [Table 9](#pharmaceuticals-01-00001-t009){ref-type="table"}, [Table 10](#pharmaceuticals-01-00001-t010){ref-type="table"}, [Table 11](#pharmaceuticals-01-00001-t011){ref-type="table"}, [Table 12](#pharmaceuticals-01-00001-t012){ref-type="table"}, [Table 13](#pharmaceuticals-01-00001-t013){ref-type="table"}, [Table 14](#pharmaceuticals-01-00001-t014){ref-type="table"}, [Table 15](#pharmaceuticals-01-00001-t015){ref-type="table"}, [Table 16](#pharmaceuticals-01-00001-t016){ref-type="table"}, [Table 17](#pharmaceuticals-01-00001-t017){ref-type="table"} summarize data about the effectiveness of antimicrobials from higher plants and antibiotic drugs against children pathogens. The selected compounds possess 'Therapeutic Indices' equal and higher than 100 units. Thus, the toxic dose towards animals is in minimum over 100 - fold higher than the inhibitory dose towards microorganism.

The results of natural antimicrobials are compared to results of antibiotic drugs obtained with resistant and non-resistant microbial strains. Because of the data variety additional information was included, which is the reported minimum and maximum MIC, the minimum and maximum TI, the number of tested strains. Of antibiotic drugs the MIC-breakpoints have frequently been determined \[[@B13-pharmaceuticals-01-00001]\]. This allows to distinguished between strains that are regarded as normal or as resistant. The minimum MIC of resistant strains is given as MIC-res for each antibiotic drug. When the quality data range for antibiotic drugs is given only \[[@B14-pharmaceuticals-01-00001]\], the double amount of the highest concentration was taken as MIC-res. TI-res is the 'Therapeutic Index' calculated from MIC-res for resistant strains, respectively. Side effects are characterized and annotated in the status field, which indicates whether a compound is used as drug ('Drug') or is listed by the Unites States Food and Drug Administration as compound that may occur in food ('Food') \[[@B15-pharmaceuticals-01-00001]\].

3. Results
==========

The results of effective compounds against causative microorganisms of children's diseases are scheduled according to [Table 3](#pharmaceuticals-01-00001-t003){ref-type="table"}.

3.1. Streptococcus pneumoniae
-----------------------------

Streptococci are human parasites, which colonize skin and mucous membranes and can be isolated from alimentary, respiratory and genital tracts. Among Pneumococci several types exist, of which capsulated strains are regarded as pathogen. Antibiotic resistances of Pneumococci isolated from children in Germany are as follows: penicillin G 8,6%, cefotaxime 3,1%, erythromycin 27,4%, tetracycline 10,7% \[[@B16-pharmaceuticals-01-00001]\]. In addition, resistances of Pneumococci towards trimethoprim, sulfonamides and chloramphenicol are reported \[[@B17-pharmaceuticals-01-00001]\]. [Table 5](#pharmaceuticals-01-00001-t005){ref-type="table"} shows the calculations on pharmaceutical drugs used for the treatment of Pneumococcus infection and the calculations of most successful compounds from higher plants in comparison. The data is sorted first by TI-res and if not available by minimum TIs.

When Pneumococci strains without resistance mechanisms were tested, the approved antibiotics dominate the list of oral TIs ([Table 5](#pharmaceuticals-01-00001-t005){ref-type="table"}), of which penicillin G is preferably be used in the therapy of Pneumococcus infections in children. The TIs of compounds from higher plants including essential oils are inferior to such therapeutically used drugs.

Pneumococci resistant to penicillin G are characterized by MIC-res \>=1 ppm, however, even at this concentration the TI-calculation for penicillin G is much better than for compounds from higher plants. Tetracycline, cotrimoxazol and chloramphenicol are not much different at their lowest level of effectiveness (TI-res) from meta-menthene-thymol **4**, meta-menthene-phenol **5**, alpha-bisabolol **6**, a component from chamomile (*Matricaria recutita*) essential oil, or lupulone **7**, a component present in hop extract (*Humulus lupulus*). However, only a small number of strains of Pneumococci have been tested with these compounds, which impairs the drawing of general conclusions.
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###### 

Effective Inhibitors of *Streptococcus pneumoniae,* oral TI ~max.~\>= 100.

  Trivial name            Animal test   LD~50~-oral mg/kg bw   n-strains   MIC-range in ppm   TI max. - TI min.   MIC-res   TI-res    Status
  ----------------------- ------------- ---------------------- ----------- ------------------ ------------------- --------- --------- ---------
  **Cefotaxime**          Mou-o         \>20000                \>100       0,004 -- 4         \>5000000 - 5000    \>2       \<10000   Drug
  **Erythromycin**        Mou-o         2580                   \>100       0,0008 -- 64       3225000 - 80        \>0,5     \<5160    Drug
  **Penicillin G**        Mou-o         \>5000                 \>100       0,008 --16         625000 -- 312       \>1       \<5000    Drug
  **Linoleic acid**       Mou-o         \>50000                2           13                 \>3846              \-\--     \-\--     Food\*
  **n-Dodecanol**         Rat-o         \>12800                2           13                 \>984               \-\--     \-\--     Food\*
  **m-Menthene-phenol**   Mou-o         2900                   1           3                  966                 \-\--     \-\--     \-\--
  **Lauric acid**         Rat-o         12000                  2           13                 923                 \-\--     \-\--     Food\*
  **Lauric aldehyde**     Rat-o         23000                  2           25                 920                 \-\--     \-\--     Food\*
  **Lupulone**            Mou-o         1500                   2           3,3                454                 \-\--     \-\--     Food
  **Sulfamethoxazole**    Mou-o         2300                   5           1 -- 8             2300 - 340          \-\--     \-\--     Drug
  **Tetracycline**        Mou-o         678                    \>100       0,12 -- 4          5650 - 170          \>2       \<340     Drug
  **Cotrimoxazol**        Mou-o         3740                   \>100       0,12 -- 32         31000 - 233         \>32      \<233     Drug
  **alpha-Bisabolol**     Rat-o         14850                  \>4         32 - 64            464 - 232           \-\--     \-\--     \-\--
  **Myristic acid**       Rat-o         \>10000                2           50                 \>200               \-\--     \-\--     Food
  **Chloramphenicol**     Mou-o         1500                   \>100       1 -- 32            1500 - 46           \>8       \<184     Drug
  **m-Menthene-thymol**   Mou-o         1925                   1           12                 160                 \-\--     \-\--     \-\-\--
  **Lauramine HCl**       Mou-o         1160                   2           10 -- 12,5         116 - 93            \-\--     \-\--     Food\*
  **Palmitic acid**       Rat-o         \>10000                3           7 -- 125           \>1428 - \>80       \-\--     \-\--     Food
  **Trimethoprim**        Mou-o         2764                   \>100       \<0,06 -- 128      \>2750 - 80         \-\--     \-\--     Drug
  **Oleic acid**          Rat-o         74000                  4           4 -- 1000          1850 - 74           \-\--     \-\--     Food\*
  **Undecylenic acid**    Mou-o         8150                   2           50 -- 1000         163 - 8             \-\--     \-\--     Drug
  **Stearic acid**        Rat-o         4600                   3           7 -- 1000          657 - 4,6           \-\--     \-\--     Food

Notes: \* may cause digestive tract irritation. Abbreviations used: -o = orally administered, Mou = mouse

The *in vitro* activity of fatty acids like oleic, linoleic and linolenic acid is inactivated by addition of blood serum \[[@B18-pharmaceuticals-01-00001]\]. Such compounds might have no practical significance in systemic treatment of infectious diseases, and therefore, they are not discussed in the following tables. The low toxicity of oleic acid and related long-chain aliphatic compounds indicate a possible use as topical antiseptics.

Treating respiratory tract infections by inhalation of volatile compounds lies near by hand. Very active compounds against *Streptococcus pneumoniae* in the vapor phase are shown in [Table 6](#pharmaceuticals-01-00001-t006){ref-type="table"}.
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###### 

Strong Inhibitors of *Streptococcus pneumoniae* in the Vapor Phase.

  Trivial name               Microorganism                       Activity evaluation   Status
  -------------------------- ----------------------------------- --------------------- ------------
  **Thymol 8**               Streptococcus pneumoniae type II    ++++                  Food \*
  **Thymol**                 Streptococcus pneumoniae type III   ++++                  Food \*
  **Thymol**                 Streptococcus pneumoniae type VI    ++++                  Food \*
  **Carvacrol 9**            Streptococcus pneumoniae type III   ++++                  Food \*^?^
  **Cinnamic aldehyde 10**   Streptococcus pneumoniae type VI    ++++                  Food \*
  **Limonene 11**            Streptococcus pneumoniae            ++++                  Food \*
  **Citronellol 12**         Streptococcus pneumoniae            ++++                  Food \*
  **Citronellal 13**         Streptococcus pneumoniae            ++++                  Food \*
  **Geraniol 14**            Streptococcus pneumoniae            ++++                  Food \*

Notes: \* may cause respiratory tract irritation, ++++: strong inhibitory activity

Almost all compounds listed in [Table 6](#pharmaceuticals-01-00001-t006){ref-type="table"}. may cause irritation of the respiratory system, and therefore, their use as therapeutics via inhalation is questionable, although thymol **8** superimposes the germicidal activity of phenol, which has a long history as disinfecting agent, about 5 to 30 times towards gram-positive bacteria. The antimicrobial properties of alpha-bisabolol are unexamined in the vapor phase. No toxic signs were observed in animal experiments following inhalation (7h exposure in a highly enriched and/or saturated atmosphere at 20 °C, Worksafe Australia). In toxicology studies alpha-bisabolol **6** was found to be safe \[[@B19-pharmaceuticals-01-00001]\]. Alpha-bisabolol strongly inhibits *Streptococcus pneumoniae* in the serial dilution tests (MIC = 32 - 64 ppm). This may explain why inhalation of vapors of chamomile flowers is recommended in German traditional medicine.

3.2. Staphylococcus aureus
--------------------------

Staphylococci are found mainly on human skin, skin glands and mucous membranes and sometimes in the mouth, blood, mammary glands, intestinal, genitourinary and upper respiratory tracts. Pathogenic strains are known to form toxins. Antibiotic resistance is reported towards ß-lactam antibiotics (oxacillin, ampicillin), aminoglycosides (gentamycin), macrolides (erythromycin), quinolones (ciprofloxacin), clindamycin, chloramphenicol, tetracycline, trimethoprim \[[@B17-pharmaceuticals-01-00001]\] and the reserve antibiotic vancomycin in 1999 \[[@B20-pharmaceuticals-01-00001]\].

In the antibiotic therapy first choice drugs are flucloxacillin (methicillin susceptible strains, MSSA), vancomycin and teicoplanin (methicillin resistant strains, MRSA) and vancomycin + flucloxacillin or vancomycin + gentamycin (glycopeptide intermediate resistant strains, GISA). Recommendations as second choice antibiotics are: cefaclor, cefuroximaxetil, and loracarbef (MSSA), quinopristin + dalfopristin, linezolid and further alternatives: vancomycin + rifampicin, cefazolin + vancomycin + netilmycin, imipenem + vancomycin + netilmycin, fusidic acid + rifampicin, Cotrimoxazol + fusic acid or rifampicin, minocycline, fosomycin + cefotaxime, and cotrimatzol + nitrofurantoin (MRSA), and quinopristin + dalfopristin, ampicillin + sulbactam, and linezolid (GISA). No differences were made in the choice of antibiotic treatment between grownups and children \[[@B16-pharmaceuticals-01-00001]\].
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###### 

Effective Inhibitors of *Staphylococcus aureus*, oral TI ~max.~ \> 100.

  Trivial name                    Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. -- TI min.   MIC-res            TI-res       Status
  ------------------------------- ------------- ---------------------- ----------- ------------------ -------------------- ------------------ ------------ --------
  **Netilmicin**                  Rat-o         Su: \>10000            \>100       0,125 -- 32        \>80000 -- 312       \>1                \>10000      Drug
  **Cefazolin**                   Mou-o         Na: \>11000            \>100       0,01 - \>256       \>110000 - \<43      0,25 -- 1          \*\*\<5500   Drug
  **Flucloxacillin**              Mou-o         Na: 7600               \>100       0,125 -- 32        60800 -- 238         \*\*\*0,125 -- 1   3800         Drug
  **Minocycline**                 Mou-o         3100                   \>100       \<0,015 - 12,5     \>206666 -- 248      0,06 - 0,5         \*\*\<3100   Drug
  **Fusidic acid**                Mou-o         1500                   \>100       0,032 -- 16        46875 - 94           \>0,5              \<3000       Drug
  **Cefotaxime**                  Mou-o         Na: \>20000            \>100       0,12 - \>60        \>166666 - \<333     0,5 - 4            \*\*\<2500   Drug
  **Cefaclor**                    Mou-o         \>20000                \>100       0,25 -- 128        \>80000 - 156        1 -- 4             \*\*\<2500   Drug
  **Vancomycin**                  Mou-o         5000                   \>100       0,125 -- 8         40000 -- 625         \>2                \<2500       Drug
  **Bakuchiol**                   Mou-o         2560                   1           1,4                1828                 \-\--              \-\--        \-\--
  **Oleic acid**                  Rat-o         74000                  3           15 -- 90           4933 - 822           \-\--              \-\--        Food
  **Mupirocin**                   Mou-o         5000                   \>100       0,05 -- 512        100000 -- 10         \>8                625          Drug
  **Gentamicin**                  Mou-o         \>10000                \>100       0,035 - \>256      \>285714 - \<39      \>16               \<624        Drug
  **Cefuroxime**                  Mou-o         \>10000                \>100       0,13 - \>60        \>76923 - \<167      \>32               \<624        Drug
  **Rifampicin**                  Mou-o         500                    \>100       0,002 - 3,1        250000 - 161         \>1                \<500        Drug
  **Loracarbef**                  Dog-o         \>2000                 \>100       0,5 -- 16          \>4000 - 125         0,5 -- 2           \*\*\<500    Drug
  **Fosfomycin**                  Mou-o         Ca: \>3500             \>100       0,5 - \>128        \>7000 - \<27        0,5 - 4            \*\*\<440    Drug
  **n-Tridecanol**                Rat-o         17200                  3           20 -- 50           860 -- 344           \-\--              \-\--        Food\*
  **Imipenem**                    Mou-o         \>5000                 \>100       0,006 -- \>256     \>833333 -- \<20     \>16               \<312        Drug
  **Teicoplanin**                 Mou-o         1000                   \>100       0,125 - 6,3        8000 - 160           \>4                \<250        Drug
  **Linoleic acid**               Mou-o         \>50000                10          4 - \>200          \>12500 - \<250      \-\--              \-\--        Food\*
  **Lupulone**                    Mou-o         1500                   7           2 - 6,25           750 -- 240           \-\--              \-\--        Food
  **Cotrimoxazol**                Mou-o         3740                   \>100       0,015 - 2,86       249333 -- 1300       \>16               \<234        Drug
  **Lauricidin**                  Rat-o         \*\*\*\*53400          11          10 -- 250          5340 -- 213          \-\--              \-\--        Food
  **3-Heptylacrolein**            Rat-o         5000                   3           25                 200                  \-\--              \-\--        Food
  **Shikonin**                    Mou-o         \>1000                 2           4 -- 5             \>250 -- 200         \-\--              \-\--        \-\--
  **Swartziadione**               Mou-o         \*\*\*\*\*\>300        1           1,56               \>192                \-\--              \-\--        \-\--
  **alpha-Bisabolol**             Mou-o         11350                  9           32 -- 100          354 - 113            \-\--              \-\--        \-\--
  **m-Menthene-phenol**           Mou-o         2900                   1           28                 103                  \-\--              \-\--        \-\--
  **Sorbic acid**                 Rat-o         7360                   50          50 -- 100          147 - 73             \-\--              \-\--        Food
  **Butylparaben**                Mou-o         13200                  20          60 -- 270          220 - 49             \-\--              \-\--        Food
  **Ampicillin-sulbactam**        Mou-o         \>6000                 \>100       \<=0,06 -- 128     \>100000 - 47        \-\--              \-\--        Drug
  **o-Methoxy-cinnamaldehyde**    Rat-o         \>5000                 3           50 -- 200          \>100 - 25           \-\--              \-\--        Food
  **Dimethyl fumarate**           Rat-o         2240                   2           10 -- 100          224 - 22             \-\--              \-\--        \-\--
  **Diethyl fumarate**            Rat-o         1780                   2           10 -- 100          178 - 18             \-\--              \-\--        \-\--
  **Lauric aldehyde**             Rat-o         23000                  8           50 - \>2000        460 - \<11,5         \-\--              \-\--        Food\*
  **ortho-Phenylphenol**          Rat-o         2000                   10          15,6 -- 200        128 - 10             \-\--              \-\--        Food
  **Nitrofurantoin**              Mou-o         360                    \>100       0,75 -- 32         480 - 11             \>32               \<11         Drug
  **n-Dodecanol**                 Rat-o         \>12800                15          12,5 - \>2000      \>1024 - \<6,4       \-\--              \-\--        Food\*
  **Linolenic acid**              Mou-o         \>3200                 8           5 -- 500           640 -- 6,4           \-\--              \-\--        Food\*
  **Undecylen aldehyde**          Rat-o         \>5000                 5           50 -- 1000         \>100 - 5            \-\--              \-\--        Food
  **Lauric acid**                 Rat-o         12000                  22          22 -- 2500         545 - 4,8            \-\--              \-\--        Food\*
  **Falcarindiol**                Mou-o         ca. 100                3           1 -- 25            100 -- 4             \-\--              \-\--        \-\--
  **Hinokitiol**                  Mou-o         760                    51          0,2 -- 200         3800 -3,8            \-\--              \-\--        \-\--
  **Capric alcohol**              Mou-o         6500                   16          40 -- 2000         162 - 3,2            \-\--              \-\--        Food
  **n-Tetradecanol**              Rat-o         32,5 ml/kg             4           40 - \>10000       812 - \<3,2          \-\--              \-\--        Food
  **Farnesol**                    Mou-o         7400                   16          25 -- 2000         123 - 3,7            \-\--              \-\--        Food
  **Isoborneol**                  Rat-o         5200                   4           50 -- 2000         104 - 2,6            \-\--              \-\--        Food
  **Hyacinthin**                  Mou-o         3890                   6           32 - \>2000        121 -- 2             \-\--              \-\--        Food
  **Nerolidol**                   Mou-o         15000                  25          25 - \>10000       600 - \<1,5          \-\--              \-\--        Food
  **Eugenol**                     Mou-o         3000                   49          25 -- 2100         120 - 1,4            \-\--              \-\--        Food
  **n-Undecyl alcohol**           Rat-o         3000                   13          25 - \>2000        120 - \<1,3          \-\--              \-\--        Food
  **Citral**                      Mou-o         6000                   49          12,5 -- 5000       480 - 1,2            \-\--              \-\--        Food
  **Diacetyl**                    Rat-o         1580                   11          \<9,75 -- 1000     \>162 - 0,16         \-\--              \-\--        Food
  **Linezolid**                   \-\--         \-\--                  \>100       0,5 -- 8           \-\--                \>4                \-\--        Drug
  **Quinupristin-dalfopristin**   \-\--         \-\--                  \>100       0,06 -- 32         \-\--                \>2                \-\--        Drug

Notes: \* may cause digestive tract irritation, **\*\*** calculated with double MIC ~max.~ of quality data range \[[@B14-pharmaceuticals-01-00001]\], **\*\*\*** range of 87 clinical isolates \[[@B21-pharmaceuticals-01-00001]\] assumed as quality data range, **\*\*\*\*** 53,4 ml/kg calculated with density = 1, **\*\*\*\*\*** LDL = lethal dose lowest. Abbreviations used: Na = Na-salt, Ca = Ca-salt, Su = sulfate-salt,

The list of effective inhibitors of *Staphylococcus aureus* is dominated again by therapeutics in use ([Table 7](#pharmaceuticals-01-00001-t007){ref-type="table"}). According to TI calculations, bakuchiol **15**, a natural long-chain phenol occurring in Malaya tea *(Psoralea corylifolia)* was the most successful compound from higher plants and it superimposes antibiotics towards which Staphylococci strains had developed a high level of resistance, e.g. mupirocin, fosfomycin or nitrofurantion. Bakuchiol was further examined on its activity against dental plaque forming microorganisms and the authors concluded that the compound is of value as food additive or as additive in mouth washes \[[@B22-pharmaceuticals-01-00001]\]. Promising *in vitro* results were again obtained with lupulone **7**. Swartziadione **16**, a constituent of the African tree *Swartzia madagascariensis*, was patented for treatment or inhibition of microbial infections. Shikonin **17**, another patented constituent of higher plants \[[@B23-pharmaceuticals-01-00001]\], occurs in the extract of Groomwell root (*Arnebia euchroma)*, which is used traditionally in China as topical wound healing therapeutic.

Further compounds having in part good results in the TI calculation are citral **18** from e.g. lemongrass (*Cymbopogon citratus*), hinokitiol **19** from the heartwood of Thuja trees, which possesses an extraordinary tropolone-ring substructure, and eugenol **3**. The wide range of activity of these compounds points to the existence of microbial resistance mechanisms and to a natural variability towards antimicrobials, which can not be explained alone with variations of the testing methods used in the examinations of the respective compounds.

Highly calculated compounds from essential oils are the sesquiterpenes nerolidol **20** and farnesol **21**, which are both methyl-substituted long-chain C-12 alcohols, and further primary alcohols having a carbon chain of 12 to 14 atoms and the monocyclic sesquiterpene alpha-bisabolol **6**.

Because *S. aureus* is also prominent for skin and wound infections, a second list on the basis of dermal 'Therapeutic indices' was calculated ([Table 8](#pharmaceuticals-01-00001-t008){ref-type="table"}).

pharmaceuticals-01-00001-t008_Table 8

###### 

Effective Inhibitors of *Staphylococcus aureus*, dermal TI ~max.~ \>= 100.

  Trivial name                     Animal test     LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  -------------------------------- --------------- ---------------------- ----------- ------------------ ------------------- --------------
  **Triclosan**                    Rabbit-dermal   9300                   10          0,01 - 0,03        930000 - 310000     Drug\*,\*\*
  **Haloprogine**                  Rabbit-dermal   1625                   6           1,56 - 3,12        1041 - 520          Drug\*,\*\*
  **Hexetidine**                   Rabbit-dermal   1,86 ml/kg             1           5                  372                 Drug
  **Linolenic acid**               Rabbit-dermal   \>20000                2           5 -- 100           \>4000 - 200        Food\*
  **Hexachlorophene**              Rabbit-dermal   \>600                  10          0,3 - 3            \>2000 - 200        Drug\*
  **Hinokitiol**                   Rabbit-dermal   \>2000                 14          0,2 - 12,5         \>10000 - 160       \-\--
  **3-Heptylacrolein**             Rabbit-dermal   3400                   2           25                 136                 Food\*
  **Oxolinic acid**                Rabbit-dermal   \>2000                 9           0,4 - 25           \>5000 - 80         Drug
  **Hydroquinone**                 Mammal-dermal   5970                   11          10 -- 90           597 - 66            Drug\*,\*\*
  **o-Methoxy-cinnamaldehyde**     Rabbit-dermal   \>5000                 3           50 -- 200          \>100 - 25          Food\*,\*\*
  **Dimethyl fumarate**            Rabbit-dermal   1250                   2           10 -- 100          125 - 12,5          \-\--\*
  **beta-Naphthol**                Rabbit-dermal   \>10000                2           100 - 1000         \>100 - 10          \-\--\*,\*\*
  **Isobornyl acetate**            Rabbit-dermal   \>20000                6           200 - \>2000       \>100 - 10          Food
  **n-Tridecanol**                 Rabbit-dermal   5600                   3           20 - \>800         280 - 7             Food\*
  **Diacetyl**                     Rabbit-dermal   \>5000                 11          9,75- 1000         \>512 - 5           Food\*
  **Hyacinthin**                   Rabbit-dermal   \>5000                 6           32 - \>1000        \>156 - 5           Food\*
  **Isoborneol**                   Rabbit-dermal   \>5000                 5           50 - \>1000        \>100 - 5           Food\*
  **Undecylen aldehyde**           Rabbit-dermal   \>5000                 5           50 -- 1000         \>100 - 5           Food\*
  **alpha-Amylcinnamyl alcohol**   Rabbit-dermal   \>5000                 6           50 - \>2000        \>100 - 2,5         Food
  **n-Undecyl alcohol**            Rabbit-dermal   4,76 ml/kg             13          25 - \>2000        190 - 2,4           Food\*
  **n-Dodecanol**                  Rabbit-dermal   \>10 ml/kg             16          12,5 - \>10000     \>800 - 1           Food\*
  **n-Tetradecanol**               Rabbit-dermal   7,13 ml/kg             25          40 - \>10000       173 - \<0,7         Food\*
  **Nerolidol**                    Rabbit-dermal   \>5000                 8           25 - \>10000       \>200 - 0,5         Food\*

Notes:\* may cause skin irritation \*\* mutagen

The most effective inhibitors of *Staphylococcus aureus* are again approved drugs used to treat skin infections. Almost all compounds listed in [Table 8](#pharmaceuticals-01-00001-t008){ref-type="table"} are classified as skin irritants. The dermal toxicity of alpha-bisabolol **6** has not been determined in numbers, however, it is regarded as safe and allergic reaction is not reported although humans are exposed to it to a large extend, because it is widely used in cosmetics. Interestingly, (+)-epi-alpha-bisabolol from *Peperomia galioides* turned out to be as active wound healing agent, when a series of commercial available terpenoids was studied \[[@B24-pharmaceuticals-01-00001]\]. A good result in the dermal TI calculation was obtained with linolenic acid **22**. It is the main constituent of the fatty oil of 'evening primrose' (*Oenanthera biennis*), which is used internally for the adjuvant treatment of neurodermitis in Germany.

Other active compounds are long-chain alcohols (C11 -- C14), nerolidol **20**, alpha-amylcinnamyl alcohol **23**, isoborneol **24** and its acetate ester, unsaturated aldehydes (3-heptylacrolein **25**, undecylen aldehyde **26**) and hinokitiol **19**.

3.3. Escherichia coli
---------------------

*Escherichia coli* belongs to the normal intestinal microflora of humans. Pathogenic strains are characterized by the ability to form toxins. Diarrhea is caused by enteropathogenic *Escherichia coli* strains. Antibiotic resistance is reported towards ß-lactam antibiotics (ampicillin), aminoglycosides, quinolones, chloramphenicol, tetracycline (doxycycline), and trimethoprim \[[@B17-pharmaceuticals-01-00001]\]. Diarrhea is treated with orally administered colistin in children and infants \[[@B16-pharmaceuticals-01-00001]\].

pharmaceuticals-01-00001-t009_Table 9

###### 

Effective Inhibitors of *Escherichia coli*, oral TI ~max.~ \>= 100.

  Trivial name           Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  ---------------------- ------------- ---------------------- ----------- ------------------ ------------------- --------------
  **Colistin**           Mou-o         LD \>2000              3           0,5 -- 10          \>4000 --200        Drug
  **trans-Nerolidol**    Mou-o         \*\*\*15000            1           \*\*\*\*125        120                 Food
  **para-Thymol**        Mou-o         6280                   2           60 -- 96           104 - 65            \-\--
  **Diethyl fumarate**   Rat-o         1780                   2           10 -- 100          178 -- 18           \-\--
  **Hinokitiol**         Rat-o         \>500                  12          1,56 -- 120        \>320 -- 6          \-\--
  **Sorbic acid**        Rat-o         7360                   11          50 - \<2000        147 - \<3,7         Food\*, \*\*
  **Butylparaben**       Mou-o         13200                  6           120 -- 4000        110 -- 3,3          Food
  **Vanillin**           Mou-o         3925                   5           25 -- 2000         157 -- 2            Food
  **Eugenol**            Mou-o         3000                   23          \<25 -- 2100       \>120 -- 1,4        Food\*
  **Linoleic acid**      Mou-o         \>50000                2           90 - \>100000      \>555 - \<0,2       Food\*
  **Citral**             Mou-o         6000                   16          12,5 -- 6660       480 -- 0            Food\*\*
  **Nerolidol**          Mou-o         15000                  4           400 -- 9500        37,5 -- 1,6         Food
  **Thymol**             Mou-o         640                    31          100 -- 1000        6,4 -- 0,6          Food\*\*

Notes: \* may cause digestive tract irritation \*\* mutagen **\*\*\*** calc. with nerolidol toxicity, **\*\*\*\*** minimal bactericidal conc.

Only a few compounds are effective inhibitors of *Escherichia coli* ([Table 9](#pharmaceuticals-01-00001-t009){ref-type="table"}). The most interesting one, a synthetic isomer of thymol **8** with the name para-thymol **27**, is about 10 times less toxic than thymol (TI ~max.~ = 6,4) itself. Not much data is available for para-thymol, e.g. spectrum of antimicrobial activity, side effects. The trans-isomer of nerolidol had strong inhibitory properties, but further testing is necessary, because stereochemically undefined nerolidol **20** was much less active. The results of hinikitiol **19** vary and were influenced by different test conditions. Variation of data is given also with citral **18**, vanillin **28** and eugenol **3**.

3.4. Salmonella species
-----------------------

*Salmonella* species have been isolated from humans and almost all animals throughout the world and they constitute another genus being prominent for causing diarrhea in humans all kind of age. Humans present the only known reservoir for *Salmonella typhi* and *paratyphi* serotypes. Resistances of *Salmonella* species towards antibiotics are reported from tetracycline, trimethoprim, quinolones and chloramphenicol \[[@B17-pharmaceuticals-01-00001]\]. In diarrhea treatment caused by *Salmonella* infections the drug of first choice is amoxicillin. Alternatively, quinolones, ceftriaxone and cotrimoxazol can be used \[[@B16-pharmaceuticals-01-00001]\].

pharmaceuticals-01-00001-t010_Table 10

###### 

Effective Inhibitors of *Salmonella* sp., oral TI ~max.~\>= 100.

  Trivial name               Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  -------------------------- ------------- ---------------------- ----------- ------------------ ------------------- --------
  **Ceftriaxone**            Mou-o         \>10000                90          0,031 -- 0,25      322000 - 40000      Drug
  **Amoxicillin**            Mou-o         \>25000                \>100       0,01 - \>100       \>2500000 - \<250   Drug
  **Isoborneol**             Rat-o         5200                   1           50                 104                 Food
  **Ciprofloxaxin**          Mou-o         5000                   \>100       0,008 -- \>64      625000 - \<78       Drug
  **Cotrimoxazol**           Mou-o         3740                   \>100       \<0,015 - \>100    250000 - \<37       Drug
  **Butylparaben**           Mou-o         13200                  6           125 -- 1000        105 -- 13           Food
  **p-Benzylphenol**         Mou-o         \>20000                2           \*160 -- 2170      \>125 -- 9          \-\--
  **Allyl isothiocyanate**   Mou-o         308                    5           1 -- 47            308 -- 6,5          Food

Notes: \* bactericidal after15 min. exposure

Similar to *Escherichia coli*, not many compounds are selected ([Table 10](#pharmaceuticals-01-00001-t010){ref-type="table"}). Allyl isothiocyanate **29** or with its more common name 'oil of mustard' (German "Senföl") is a very irritant compound with pungent taste. Its inhibitory data as well as the data of the preservative butylparaben **30** is not conclusive due to the small number of tested *Salmonella* strains, respectively. Nevertheless, butylparaben was shown previously as effective compound against *E. coli*. Only one data record exists with isoborneol **24**, which occurs together with borneol as main constituents of the essential oil of annual wormwood (*Artemisia annua*), a plant growing in India.

3.5. Mycobacterium tuberculosis
-------------------------------

Most species of Mycobacteria are living in soil or water in contrast to microorganisms belonging to the *Mycobacterium tuberculosis* complex (*M. bovis, M. microti*, and *M. africanum, M. tuberculosis*), which are found in diseased tissues of humans and warm-blooded animals suffering on tuberculosis. Resistances are found in particular towards all antibiotic drugs (ethambutol, rifampicin, streptomycin, isoniazid, and pyrazinamide), which represents a global problem \[[@B17-pharmaceuticals-01-00001]\]. The calculation of TIs resulted in a new ranking favoring compounds from higher plants ([Table 11](#pharmaceuticals-01-00001-t011){ref-type="table"}).

pharmaceuticals-01-00001-t011_Table 11

###### 

Effective Inhibitors of *Mycobacterium tuberculosis*, oral TI ~max.~ \>= 100.

  Trivial name            Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   MIC-res    TI-res   Status
  ----------------------- ------------- ---------------------- ----------- ------------------ ------------------- ---------- -------- --------
  **cis-Phytol**          Rat-o         \*\*\>5000             1           2                  \>2500              \-\--      \-\--    \-\--
  **Ethambutol**          Mou-o         8700                   \>10        0,95 -- 7,5        9157 -- 1160        \*\*\*10   870      Drug
  **Sclareol**            Rat-o         \>5000                 1           6                  \>833               \-\--      \-\--    \-\--
  **Farnesol**            Mou-o         7400                   1           8                  825                 \-\--      \-\--    Food
  **Propylparaben**       Mou-o         6332                   1           8                  791                 \-\--      \-\--    Food
  **Phenyl salicylate**   Rat-o         3000                   1           4                  750                 \-\--      \-\--    Drug
  **trans-Phytol**        Rat-o         \*\*\>5000             4           2 -- 8             \>2500 -- 625       \-\--      \-\--    \-\--
  **Streptomycin**        Rat-o         9000                   \>30        0,1 -- 100         5000 - 5            \*\*\*16   560      Drug
  **Rifampicin**          Mou-o         500                    \>100       0,01 -- 16         50000 -- 31         \*\*\*2    250      Drug
  **beta-Naphthol**       Rat-o         1960                   1           8                  245                 \-\--      \-\--    Drug
  **alpha-Naphtol**       Rat-o         1870                   1           8                  233                 \-\--      \-\--    \-\--
  **Methylparaben**       Mou-o         \>8000                 1           40                 \>200               \-\--      \-\--    Food
  **Pyrazinamide**        Mou-o         \>3000                 \>20        4 - 4000           \>750 -- 0,7        \*\*\*16   187      Drug
  **asym.-m-Xylenol**     Rat-o         3200                   1           40                 160                 \-\--      \-\--    \-\--
  **Retinoic acid**       Rat-o         1960                   3           13                 150                 \-\--      \-\--    Food
  **Isoniazid**           Mou-o         133                    \>50        0,01 -- 100        13300 -- 1          \*\*\*1    133      Drug
  **4-Hexylresorcinol**   Mou-o         1040                   2           \* 1 - 8           1040 - 130          \-\--      \-\--    Drug
  **Bakuchiol**           Mou-o         2560                   1           10 - 20            256 -- 128          \-\--      \-\--    \-\--
  **Retinol**             Mou-o         4000                   3           40 - 50            100 - 80            \-\--      \-\--    Food
  **Lupulone**            Mou-o         1500                   13          10 -- 110          150 -- 14           \-\--      \-\--    \-\--
  **Thymol**              Rat-o         980                    7           8 -- 100           122 -- 10           \-\--      \-\--    Food

Notes: **\*** bactericidal conc., **\*\*** calc. both with toxicity of pythol, \*\*\* estimated MIC for resistant strains

The results indicate that several constituents from higher plants seem to be superior to antibiotic drugs being used for therapy of tuberculosis, however, only a small number of strains have been tested so far. Beside sclareol **31** from Clary Sage (*Salvia sclarea*) the hop (*Humulus lupulus*) constituent lupulone **7** was selected among most effective inhibitors. The latter was once tested in tuberculosis infected mice, which had received intramuscularly injections of 60 mg/kg body weight over a 4 weeks period, but the renal toxicity of lupulone prevented its development as pharmaceutical drug \[[@B25-pharmaceuticals-01-00001]\].

Other compounds of [Table 11](#pharmaceuticals-01-00001-t011){ref-type="table"} can be classified in three groups: long-chain aliphatic compounds, aromatic acid esters and phenols.

The selected compounds of group 1, cis- **32** and trans-phytol **33**, farnesol **21**, retinoic acid **34** and retinol **35** possess structural similarities, which are in particular a long side chain consisting of 3 to 4 isoprene-units plus a terminal polar group. Similarly, fatty acids were strong inhibitors *in vitro* (data not shown). However, the effectiveness *in vivo* of all selected lipophilic compounds seems to be questionable due to their possible adsorption to lipophilic lung tissue and inactivation.

Surprisingly, preservatives like methyl- **36** and propylparaben **37** are very successful in the TI-calculations. A further ester of aromatic acids, phenyl salicylate **38**, is well known as anti-infective drug for a long time.

The third group consists of phenols (asym.-m-xylenol **39**, 4-hexylresorcinol **40**, alpha- **41** and beta-naphtol **42,** bakuchiol **15**) having a similar range of lipophilicity, of which bakuchiol is the most fat-soluble representative.

In comparison with the water solubility of antitubercular drugs, all investigated compounds are less soluble in water, which might prevent their use as lung therapeutics.

3.6. Dermatophytes
------------------

Skin and hair infections of children (*Tinea capitis*) are caused by dermatophytes belonging to the genera *Trichophyton* and *Microsporum*. They occur either in soil or possess host preference (humans or animals), e.g. *Microsporum canis* infections are often result of contact between susceptible children and stray kittens \[[@B17-pharmaceuticals-01-00001]\]. The calculations made with *Microsporum* species, compounds from higher plants and orally administered antifungal drugs are shown in [Table 12](#pharmaceuticals-01-00001-t012){ref-type="table"}.

Interestingly, a series of 1'-oxo-substituted phloroglucinols **43** turned out to be as successful and non-toxic inhibitors of *Microsporum* species. Good results were obtained again with bakuchiol **15** and alpha-hederin **44**, which originates from hederasaponine C, the main saponine of Common Ivy (*Hedera helix*). Alpha-hederin was found to be non-toxic following oral administration, but it was rather toxic when given intravenously. Undecylenic acid **45**, a naturally occurring compound, has a long history as antifungal drug. When compared with the lowest level of activity of antibiotics, the effectiveness of alpha-bisabolol **6** was similar to griseofulvin, nystatin, fluconazole, itraconazole and ketoconazole. Other compounds seem be to of minor importance, e.g. o-methoxycinnamaldehyde **46**, due to their mutagenic or tumorigenic properties.

pharmaceuticals-01-00001-t012_Table 12

###### 

Effective Inhibitors of *Microsporum* Species, oral TI ~max.~ \>= 100.

  Trivial name                                                       Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  ------------------------------------------------------------------ ------------- ---------------------- ----------- ------------------ ------------------- ------------
  **Terbinafine**                                                    Mou-o         4000                   \>40        0,002 - 1          2000000 -- 4000     Drug
  **Oenanthic acid**                                                 Mou-o         6400                   2           2                  3200                Food
  **Amphotericin B**                                                 Mou-o         \>8000                 \>100       0,125 - 8          \>64000 - 1000      Drug
  **Decanoic acid**                                                  Rat-o         \>10000                2           12,5               \>800               Food\*
  **o-Methoxycinnamaldehyde**                                        Mou-o         4430                   2           3,13 - 6,25        1415 - 708          Food\*\*\*
  **Pelargonic acid**                                                Rat-o         3200                   2           2 -- 5             1600 -- 640         Food\*
  **1-(2,4,6-Trihydroxy- 3-isobutyl-phenyl)-hexan-1-one**            Mou-o         \>1000                 1           1,6                \>625               \-\--
  **Bakuchiol**                                                      Mou-o         2560                   5           0,5 - 5            27777 - 512         \-\--
  **1-(3-Butyryl-2,4,6-trihydroxy-phenyl)-butan-1-one**              Mou-o         \>1000                 1           3                  \>333               \-\--
  **4-(1,1-Dimethylethyl)phenol**                                    Rat-o         3250                   2           10                 325                 \-\--\*\*
  **alpha-Hederin**                                                  Mou-o         \>4000                 1           12,5               \>320               \-\--
  **Thiabendazole**                                                  Mou-o         2400                   10          0,2 - 7,8          12000 -- 307        Drug
  **alpha-Bisabolol \*\*\*\***                                       Rat-o         14850                  1           50                 297                 Food
  **Griseofulvin**                                                   Mou-o         \>5000                 \>100       0,25 - 25          \>20000 -- 200      Drug
  **4-Methyl-1-(2,4,6-trihydroxy-3-isobutyl-phenyl)-pentan-1-one**   Mou-o         1000                   1           6                  166                 \-\--
  **Cyclohexyl-(2,4,6-trihydroxy-3-isobutyl-phenyl)-methanone**      Mou-o         \>1000                 1           6                  \>166               \-\--
  **1-(3-Allyl-2,4,6-trihydroxy-phenyl)-propan-1-one**               Mou-o         \>1000                 1           6                  \>166               \-\--
  **1-(3-Allyl-2,4,6-trihydroxy-phenyl)-hexan-1-one**                Mou-o         \>1000                 1           6                  \>166               \-\--
  **1-(3-Allyl-2,4,6-trihydroxy-phenyl)-4-methyl-pentan-1-one**      Mou-o         \>1000                 1           6                  \>166               \-\--
  **1-(3-Benzyl-2,4,6-trihydroxy-phenyl)-4-methyl-pentan-1-one**     Mou-o         1000                   1           6                  166                 \-\--
  **1-(5,7-Dihydroxy-2,2-dimethyl-chroman-8-yl)-butan-1-one**        Mou-o         \>1000                 1           6                  \>166               \-\--
  **Nystatin**                                                       Mou-o         8000                   10          \<0,1 - 50         80000 - 160         Drug
  **Lauric acid**                                                    Rat-o         12000                  100         100                120                 Food\*
  **Undecylenic acid**                                               Mou-o         8150                   6           25 - 100           326 - 81            Drug\*
  **Fluconazole**                                                    Mou-o         1408                   \>100       0,06 - \>64        23467 - 33          Drug
  **Itraconazole**                                                   Mou-o         \>320                  \>100       0,03 - 10          \>10666 - 32        Drug
  **Citral**                                                         Mou-o         6000                   3           20 - 190           288 - 31            Food\*\*\*
  **Ketoconazole**                                                   Mou-o         618                    \>100       0,01 - 50          61800 - 12          Drug
  **Miconazole**                                                     Mou-iv        \*\*\*\*\*90           \>100       0,01 - 16          9000 -- 6           Drug

Notes: \* may cause digestive tract irritation, \*\* tumorigen, \*\*\* mutagen, **\*\*\*\*** active against 'dermatophytes', **\*\*\*\*\*** intravenous LD~50~

When the activity of essential oil and related compounds was examined on their effectiveness against *Trichophyton* species three sesquiterpene alcohols and two C-11 alcohols were selected ([Table 13](#pharmaceuticals-01-00001-t013){ref-type="table"}).

pharmaceuticals-01-00001-t013_Table 13

###### 

Effective Inhibitors of *Trichophyton* Species, oral TI ~max.~ \>= 100.

  Trivial name                      Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  --------------------------------- ------------- ---------------------- ----------- ------------------ ------------------- --------------
  **Undecylenic alcohol**           Rat-o         \>5000                 1           10                 500                 Food\*
  **Farnesol**                      Rat-o         6000                   1           12,5               480                 Food
  **Nerolidol**                     Rat-o         \>5000                 1           12,5               400                 Food
  **4-(1,1-Dimethylethyl)phenol**   Rat-o         3250 ul/kg             5           10                 325                 \-\--\*\*\*
  **n-Undecyl alcohol**             Rat-o         3000                   1           12,5               240                 Food\*
  **alpha-Bisabolol**               Rat-o         14850                  6           50 -- 100          297 -- 149          Food
  **Piperonal**                     Rat-o         2700                   1           25                 108                 Food\*, \*\*
  **cis-Jasmone**                   Rat-o         5000                   1           50                 100                 Food\*
  **Cinnamic aldehyde**             Rat-o         2220                   18          5 -- 400           444 -- 1            Food\*, \*\*

Notes: \* may cause skin irritation, \*\* mutagen, \*\*\* tumorigen

The structures of further effective inhibitors (4-(1,1-dimethylethyl)phenol **47**, piperonal **48**, cis-jasmone **49**) are shown next, which are all reported to have undesired side effects.

To get information about the most successful compounds by the way of dermal application, the TIs of compounds against *Microsporum* species were calculated. As result, only a few compounds were selected as effective inhibitors and none of the investigated natural compounds were free of side effects. The highest calculations were obtained with the synthetic antifungal drugs haloprogine and triclosan ([Table 14](#pharmaceuticals-01-00001-t014){ref-type="table"}).

pharmaceuticals-01-00001-t014_Table 14

###### 

Effective Inhibitors of *Microsporum* Species, dermal TI ~max.~ \>= 100.

  Trivial name                      Animal test     LD~50~-dermal mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  --------------------------------- --------------- ------------------------ ----------- ------------------ ------------------- -----------
  **Haloprogine**                   Rabbit-dermal   1625                     10          0,001 - 0,4        1625000 - 4062      Drug
  **Triclosan**                     Rabbit-dermal   9300                     5           1 -- 10            9300 - 930          Drug
  **o-Methoxycinnamaldehyde**       Rabbit-dermal   \>5000                   2           3,13 -- 6,25       \>1597 -- 625       Food\*
  **4-(1,1-Dimethylethyl)phenol**   Rabbit-dermal   2520                     1           10                 252                 \-\--\*\*
  **Citral**                        Rabbit-dermal   2250                     3           20,8 -- 190        108 - 12            Food\*
  **Hexachlorophene**               Rat-dermal      \>600                    7           1 -- 100           \>600 - 6           Drug

Notes: \*mutagen, \*\* tumorigen

It would be desirable to compare dermal TIs of natural compounds with drugs used to treat topical fungal infection. However, the dermal toxicity of most of topical antifungal drugs is not published \[[@B10-pharmaceuticals-01-00001]\]. A list of TIs calculated with oral toxicity data is shown below ([Table 15](#pharmaceuticals-01-00001-t015){ref-type="table"}).

pharmaceuticals-01-00001-t015_Table 15

###### 

Effectiveness of Topical Antifungals towards *Microsporum* Species.

  Trivial name         Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  -------------------- ------------- ---------------------- ----------- ------------------ ------------------- --------
  **Tolciclate**       Mou-o         4000                   \>20        0,001 - 0,13       1000000 - 64516     Drug
  **Sulconazole**      Mou-o         nitrate: 2475          2           \<0,04 -- 0,08     \>61875 -- 30937    Drug
  **Siccanin**         Mou-o         \>6000                 2           0,8 - 1,6          \>7500 - 3750       Drug
  **Oxiconazole**      Mou-o         nitrate: 2630          2           0,3 - 1            8766 - 2630         Drug
  **Tioconazole**      Mou-o         1870                   10          0,2 - 1,56         9350 - 1200         Drug
  **Fenticonazole**    Mou-o         \>3000                 1           2,5                \>1200              Drug
  **Amphotericin B**   Mou-o         \>8000                 \>100       0,125 - 8          \>64000 - 1000      Drug
  **Amorolfin**        Mou-o         400                    50          0,001 - 0,2        400000 - 800        Drug
  **Bifonazole**       Mou-o         2629                   \>100       0,025 - 5          105000 - 525        Drug
  **Triclosan**        Mou-o         4530                   4           0 - 10             4530 -- 453         Drug
  **Flutrimazole**     Mou-o         \>1000                 14          0,025 - 2,5        \>40000 -- 400      Drug
  **Econazole**        Mou-o         nitrate: 463           10          0,03 - 12,5        15433 -- 370        Drug
  **Clotrimazol**      Mou-o         923                    \>100       0,01 - 2,69        92300 -- 369        Drug
  **Ciclopirox**       Mou-o         1740                   \>40        0,98 - 10          1775 -- 174         Drug
  **Nystatin**         Mou-o         8000                   10          \<0,1 - 50         80000 - 160         Drug
  **Natamycin**        Mou-o         1500                   1           12,5               120                 Drug
  **Haloprogine**      Mou-o         LD \>3000              7           31,2               \>2000000 - 96      Drug
  **Miconazole**       Mou-o         519                    \>100       0,01 - 16          51900 - 16          Drug
  **Ketoconazole**     Mou-o         618                    \>100       0,01 - 50          61800 - 12          Drug
  **Tolnaftate**       Mou-o         10000                  \>60        0,0015 - 1000      6666666 - 10        Drug
  **Protiofate**       Mou-o         423                    8           0,78 - 50          542 - 8             Drug

3.7. Candida albicans
---------------------

Yeasts live as normal microorganisms in and on the human body. Many species are without any clinical significance, however, some of them develop pathological changes in debilitated persons, e.g. following administration of anticancer drugs or immunsuppressive agents such as corticosteroids and by overuse of broad-spectrum antibiotics \[[@B17-pharmaceuticals-01-00001]\]. *Candida albicans* causes systemic and topical infections in children, and therefore, respective TIs are calculated for oral ([Table 16](#pharmaceuticals-01-00001-t016){ref-type="table"}) and topical ([Table 17](#pharmaceuticals-01-00001-t017){ref-type="table"}) administration routes.

pharmaceuticals-01-00001-t016_Table 16

###### 

Effective Inhibitors of *Candida albicans*, oral TI ~max.~\>= 100.

  Trivial name                      Animal test   LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  --------------------------------- ------------- ---------------------- ----------- ------------------ ------------------- ------------
  **Lapachol**                      Mou-o         487                    1           0,03               16233               \-\--
  **Dodecanal**                     Rat-o         23000                  1           25                 920                 Food\*
  **Linoleic acid**                 Mou-o         \>50000                1           125                \>400               Food\*
  **Swartziadione**                 Mou-o         LDL0 \>300             1           0,78               \>384               \-\--
  **Cerulenin**                     Mou-o         547                    1           \<1,5              \>364               \-\--
  **Amphotericin B**                Mou-o         \>8000                 \>100       0,02 - 25          \>400000 - 320      Drug
  **Ketoconazole**                  Mou-o         618                    \>100       0,039 - 2          19776 - 309         Drug
  **Nystatin**                      Mou-o         8000                   \>100       0,78 - 33          10256 - 242         Drug
  **Oenanthic acid**                Mou-o         6400                   1           32,5               197                 Food
  **Fluconazole**                   Mou-o         1408                   \>100       \<=0,0313 - 8      \>45000 - 176       Drug
  **Flucytosine**                   Mou-o         \>15000                \>100       0,005 - \>128      \>3000000 - \<117   Drug
  **4-(1,1-Dimethylethyl)phenol**   Rat-o         3250                   1           31,25              104                 \-\--\*\*
  **Butylparaben**                  Mou-o         13200                  6           75 - 130           176 - 101           Food
  **o-Methoxycinnamaldehyde**       Rat-o         \>5000                 3           50                 \>100               Food\*\*\*
  **Decylenic alcohol**             Rat-o         \>10000                1           100                \>100               \-\--
  **Octanoic acid**                 Rat-o         10080                  2           18 -- 145          560 -- 69           Food\*
  **alpha-Bisabolol**               Mou-o         11350                  4           100 -- 500         113 - 22            \-\--
  **Miconazole**                    Mou-iv        90                     82          0,02 - \>25        4500 - \<3,6        Drug
  **Citral**                        Mou-o         6000                   16          10 -- 10000        600 -- 0            Food
  **n-Dodecanol**                   Rat-o         \>12800                2           25 -- 100000       \>512 - 0           Food\*
  **Undecylenic acid**              Mou-o         8150                   1           70 -- 1000         116 - 8             Drug\*
  **Sorbic acid**                   Mou-o         3200                   1           25 -- 10000        128 - 0             Food

Notes: \* may cause digestive tract irritation, \*\* tumorigen, \*\*\* mutagen

The most successful compound against *Candida albicans* was lapachol **50** according to the oral TI calculations. Lapachol is a green-yellow substance found in the inner bark of Brazilian Taheboo tree (*Tabebuia avellanedae*), which is traditionally used in South America to treat *Candida* and bacterial infections. Lapachol inhibited growth of *Candida albicans* at a very low concentration, but the germicidal concentration was found to be much higher (32 ppm). Beside long-chains aliphatics having a terminal polar group and 8 to 12 carbon atoms, swartziadione **16** was selected, a structurally related compound to lapachol, and in addition, cerulenin **51** from microbial origin (e.g. *Cephalosporium caerulens*). Cerulenin was found to inhibit growth of yeast-type fungi by inhibiting the biosynthesis of fatty acids \[[@B26-pharmaceuticals-01-00001]\]. All before mentioned compounds superimpose the minimum TIs of orally administered antibiotics usually taken to treat *Candida* infections. Among terpenoids only alpha-bisabolol resulted in promising a TI, while acute toxicity data of other interesting compounds have not been determined.

When calculating dermal TIs of anti-candidal drugs no results were calculable with standard therapeutics amphothericin B, nystatin, clotrimazole and miconazol due to missing acute dermal toxicity data \[[@B10-pharmaceuticals-01-00001]\]. The residual calculations of the most effective compounds are shown in [Table 17](#pharmaceuticals-01-00001-t017){ref-type="table"}.

pharmaceuticals-01-00001-t017_Table 17

###### 

Effective Inhibitors of *Candida albicans*, dermal TI ~max.~\>= 100.

  Trivial name                  Animal test     LD~50~-oral mg/kg bw   n-strains   MIC range in ppm   TI max. - TI min.   Status
  ----------------------------- --------------- ---------------------- ----------- ------------------ ------------------- ------------------
  **Capsaicin**                 Mou-dermal      \>512                  1           \<1,5              \>340               Food\*\*, \*\*\*
  **Triclosan**                 Rabbit-dermal   9300                   12          10 - 33            930 - 282           Drug
  **Haloprogine**               Rabbit-dermal   1625                   \>100       0,05 - 6,25        32500 - 260         Drug
  **Sclareol**                  Rabbit-dermal   \>5000                 1           32                 \>156               \-\--
  **Undecanal**                 Rabbit-dermal   \>5000                 1           50                 \>100               Food\*
  **o-Methoxycinnamaldehyde**   Rabbit-dermal   \>5000                 2           50                 \>100               Food\*\*
  **Cloconazole**               Rabbit-dermal   HCl: \>310             \>100       0,12 - 8           \>160 - 39          Drug
  **Caprylic acid**             Rabbit-dermal   \>5000                 4           18 - 1000          \>277 - 5           Food\*
  **Camphor**                   Rabbit-dermal   \>5000                 5           50 - 2000          \>100 - 2,5         Food\*
  **Citral**                    Rabbit-dermal   2250                   17          10 - 10000         225 - 0             Food\*, \*\*

Notes: \* may cause skin irritation, \*\*mutagen, \*\*\* tumorigen

Only a few effective compounds were found, of which the most successful compound is sclareol **31** from Clary Sage (*Salvia sclarea*). This compound was patented to treat human fungal infections and its recommended to be used internally at daily doses of 1 to 1000 mg/kg \[[@B27-pharmaceuticals-01-00001]\]. Other compounds may have undesired side effects, such as capsaicin **52,** the main compound in Chilly (*Capsicum frutescens*) or Red Pepper (*Capsicum annuum*).

Alpha-bisabolol (MIC = 100 ppm) **6** is widely used in topical cosmetic preparations and it is regarded as safe on human skin, although its numeric dermal LD~50~ value has not been published \[[@B19-pharmaceuticals-01-00001]\]. A few other compounds show also promising activity against *Candida albicans*, however, their acute toxicity is unknown. These compounds are commercially available elemol (MIC = 70 ppm) **53**, while others (3,6-epoxydioxy-bisabola-1,10-diene: MIC: 6,25 ppm **54**, linderazulene: 12,5 ppm **55** and caryophyllodienol: 12,5 ppm **56**) are isolated from plants only in a few cases.

3.8. Other Important Microorganisms Causing Children's Infections
-----------------------------------------------------------------

About causative microorganism of other important diseases typical for children, such like pertussis, epiglottis, tetanus and diphtheria, not much information is obtained about effective inhibitors in TI calculations.

*Bordetella pertussis* (responsible for pertussis) was found to be susceptible towards aliphatic acids. No effective compound was found in the cases of *Haemophilus influenzae* (epiglottis) and *Clostridium tetani* (tetanus). Alpha-bisabolol (oral TI \> 200) **6** and to a lesser extend camphor (oral TI = 90) **2** were effective against the diphtheria causing microorganism *Corynebacterium diphtheriae*.

4. Discussion
=============

The effectiveness of antibiotics used to treat children's diseases is superior to that of compounds produced by higher plants according to the before mentioned criteria and data analysis.

The antimicrobial plant constituents differ in their spectrum of activity from antibiotic drugs and show only poor effectiveness against gram-negative pathogens, such like *Escherichia coli, Salmonella species, Bordetella pertussis* and *Haemophilus influenzae*. Several effective inhibitors of low mammalian toxicity (TI ~min.~ \>100) were selected in the analysis with gram-positive bacteria: *Streptococcus pneumoniae* (m-menthene-phenol **5**, alpha-bisabolol **6**, lupulone **7**), *Staphylococcus aureus* (m-menthene-phenol **5**, alpha-bisabolol **6**, lupulone **7**, bakuchiol **15**, swartziadione **16**, shikonin **17**, hinokitiol **19**) and *Mycobacterium tuberculosis* (bakuchiol **15**, farnesol **21**, sclareol **31**, cis- **32** and trans-phytol **33**, vitamin A acid **34**, methyl- **36** and propylparaben **37**, phenylsalicylate **38**, asym.-m-xylenol **39**, hexyresorcinol **40**, alpha- **41** and beta-naphthol **42**). As effective inhibitors of dermatophytic fungi were found: alpha-bisabolol **6**, bakuchiol **15**, nerolidol **20**, farnesol **21**, a series of phenylbutanone derivatives **43**, alpha-hederin **44**, o-methoxycinnamaldehyde **46**, 4-(1,1-dimethylethyl)phenol **47**, piperonal **48**, and cis-jasmone **49**. As the most successful compound against *Candida albicans* turned out to be: swartziadione **15**, sclareol **31**, lapachol **50**, capsaicin **52**. In addition, alpha-bisabolol **6** was effective against *Corynebacterium diphtheriae*.

Among the typical components of essential oils especially sesquiterpene and diterpene alcohols were selected (alpha-bisabolol **6**, nerolidol **20**, farnesol **21**, cis- **32** and trans-phytol **33**, sclareol **31**). Monoterpenes, such as thymol **8** or carvacrol **9**, and phenylpropanes, such as eugenol **3**, being prominent for their antimicrobial activity failed in this analysis due to their comparatively high mammalian toxicity.

Not many of the isolated natural inhibitors of children's pathogens have been tested against a greater number of microbial strains of one species as it the case with standard therapeutics. Thus, the ranges of antimicrobial activity are generally unknown, which are important for the judgement about the usefulness of such compounds as therapeutic agent. Another important topic aspect is the use of non-standardized test methods in microbiology, which also causes variation of data.

The calculation of oral TIs aimed to analyze the effectiveness of compounds by oral application. Other than in laboratory *in vitro* experiments an orally administered compound undergoes metabolic changes inside the body of living organism. For instance, the metabolites of trans-anethole **57**, the main constituent of the essential oil of anise *(Pimpinella anisum*), were studied in two human volunteers \[[@B28-pharmaceuticals-01-00001]\]. Following ingestion of 1 mg methoxy ^14^C-labelled trans-anethole approx. 21% of the administered dose was demethylated within 8 hours as it could be determined by the amount of exhaled ^14^CO~2~. Within 24 hours approx. 65% of the totally administered radioactivity was found in the urine, while about 10% of the radioactivity was not recovered ([Figure 2](#pharmaceuticals-01-00001-f002){ref-type="fig"}).

![Metabolization of Orally Administered trans-Anethole in Humans.](pharmaceuticals-01-00001-g002){#pharmaceuticals-01-00001-f002}

Among urinary metabolites main conversion products were *O*-demethylated compounds and compounds of known structure **57** to **62**. This rapid biotransformation of a trans-anethole may help to interpret the findings obtained in a comparative *in vivo - in vitro* study with mycobacteria and trans-anethole \[[@B29-pharmaceuticals-01-00001]\]. Anethole was most effective in tuberculosis protection of guinea pigs *in vivo*, but failed to have considerable activity *in vitro* ([Table 18](#pharmaceuticals-01-00001-t018){ref-type="table"}).

pharmaceuticals-01-00001-t018_Table 18

###### 

Comparison of the *in vitro* Inhibition of *Mycobacterium tuberculosis* by Essential Oils and some of their Components with the *in vivo* Disease Protection by such Materials of Guinea Pigs Infected with Tubercle bacilli.

  Test materials   *in vivo*   *in vitro*
  ---------------- ----------- ------------
  Anethole         ++++        ++
  Lemon oil        +++         \+
  Nutmeg oil       ++          \+
  Terpineol        ++          ++++
  d-Limonene       \+          +++
  l-Limonene       \+          +++
  Geraniol         \+          ++
  Eugenol          \+          ++++
  d-Pinene         \+          +++
  l-Pinene         \-          ++

Notes: ++++ very active, +++ moderate active, ++ active, poor effect, - no effect

By means of these results, it is obvious that the effects of test compounds can not be explained with *in vitro* testing alone, although this method-strategy was successful many times in antibiotic research.

If a metabolizing system, however, is absent or plays a minor role, the active compound is available without major losses. Treatment of localized infections of outer and inner surfaces of the body with antimicrobials from higher plants is imaginable, e.g. topical application onto skin, inhalation (respiratory tract) and ingestion (gastrointestinal tract).

The compounds selected on the basis of dermal toxicity data are may be useful in the therapy or support of therapy of localized skin infections. Especially, several alcohols occurring in essential oils were effective against hair and skin pathogens, which are n-undecanol, n-undecenol, alpha-bisabolol **6**, nerolidol **20** and farnesol **21**.

Inhalation of volatile antimicrobials causes direct contact to undesired microorganisms present on mucous membranes of the respiratory tract. Similar to entire essential oils, a treatment of respiratory tract diseases with selected compounds from essential oils is imaginable.

In the gastrointestinal tract structural changes of essential oil compounds are known and influence in part markedly the chemical constitution. For instance, reports exist on rapid rearrangement of linalool to geraniol **14** through influence of gastric juice in the stomach \[[@B30-pharmaceuticals-01-00001]\], or the formation 3,4-dihydroxy-propylbenzene from methyl isoeugenol (3,4-dimethoxy-1-propenylbenzene) by action of the caecal microbial flora \[[@B31-pharmaceuticals-01-00001]\].

Appearance of essential oil compounds in the bloodstream following administration to skin and percutaneous resorption \[[@B32-pharmaceuticals-01-00001]\] or following inhalation \[[@B33-pharmaceuticals-01-00001]\] was demonstrated in humans and animals, respectively, which implies further pharmacological effects.

Among compounds found in essential oils, alpha-bisabolol **6** from Chamomile turned out to be safe following inhalation and simultaneously it is inhibitory to several microbial species pathogenic for children.

5. Conclusion
=============

A comparison of the effectiveness of natural compounds with such of antibiotics on the basis of oral 'Therapeutic Indices' calculations revealed that natural compounds are inferior to antibiotics in general. The natural compounds are mild oral antimicrobials and they are unfit to treat severe infections of children.

Only in the case of tuberculosis several natural compounds of low mammalian toxicity and strong *in vitro* activity exist, however, these findings need further verification in living organisms.

Despite the limited value of essential oil compounds as oral antibiotics, the dermal 'Therapeutic Index' calculations may lead to findings, which are helpful in the therapy or in the supportive therapy of skin infections in children. Inhalation of isolated compounds from essential oil may be also useful in the support of therapy of respiratory tract infections.

This data analysis shows that the natural resources of antimicrobials are not fully explored. The effectiveness of most of the natural compounds as antimicrobials cannot be fully evaluated due to many missing toxicity data. The existing data material on volatile sesquiterpenes indicates their low mammalian toxicity and relatively strong antimicrobial activity, and therefore, this group of compounds turned out to be the most interesting one.
